Theralymph : An innovative therapy for lymphedema
THERALYMPH
OUR MAIN OBJECTIVES
Describe the physiopathology of lymphedema to better understand mechanisms of loss of lymphatic function.
Identify therapeutic targets for lymphedema to restore the lymphatic flow.
Validate therapeutic targets in preclinic models of lymphedema.
Perform a Phase I/IIa gene therapy clinical trial on patients who developed lymphedema after breast cancer using lentiflash vectors.
Workpackages
Partners
Months
NEws
Follow Along
Click here to discover Theralymph Gene therapy for lymphedema
Post-doctoral Position to study experimental secondary lymphedema
GIGA-Cancer, LBTD, University of Liege, Belgium A 2-years post-doctoral position is available now in the Agnès Noel’s lab group (starting in January 2023 or Spring 2023) at the GIGA-Cancer to work in the context of the TheraLymph Horizon 2020...
Post-doctoral position at I2MC-Toulouse (France)
Post-doctoral position at I2MC-Toulouse (France) : Theralymph : An innovative therapy for lymphedema A postdoctoral position, with salary funded for three years is available in the team “Molecular regulations of (lymph)angiogenic growth factors in vascular diseases”...
Theralymph Events
